Roche And Synta Ink Collaboration | January 12, 2009 Issue - Vol. 87 Issue 2 | Chemical & Engineering News
Volume 87 Issue 2 | p. 27 | Concentrates
Issue Date: January 12, 2009

Roche And Synta Ink Collaboration

Department: Business

Synta Pharmaceuticals and Roche have formed an alliance to develop small-molecule drugs targeting a novel family of ion channels critical to immune cell function known as calcium-release-activated calcium-modulator channels. Under the terms of the agreement, Roche will fund research to be conducted by Synta during an initial two-year research period and receive worldwide rights to develop and commercialize certain products. Synta will receive $25 million in up-front license fees and research support.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment